Menu
CHAMOMILLA RECUTITA (MATRICARIA) FLOWER WATER
Score:
Data: Limited
- Other Concerns
- Functions
- About the Chemical
- Synonyms
-
Use restrictions (low) and Neurotoxicity (low)
Cancer 
Cancer: Ingredients linked to cancer in government, industry or academic studies or assessments.
Developmental & Reproductive Toxicity
Developmental and reproductive toxicity: Ingredients linked to developmental and reproductive toxicity, a broad class of health effects that range from infertility and reproductive organ cancers to birth defects and developmental delays in children.
Allergies & Immunotoxicity
Allergies and immunotoxicity: Ingredients linked to harm to the immune system, a class of health problems that manifest as allergic reactions or an impaired capacity to fight disease and repair damaged tissue in the body.
Products with this Ingredient
| facial moisturizer/treatment | 7 products |
| mask | 4 products |
| toners/astringents | 4 products |
| facial cleanser | 3 products |
| serums & essences | 3 products |
| moisturizer | 2 products |
| anti-aging | 2 products |
| hand cream | 1 products |
| baby soap | 1 products |
| baby shampoo | 1 products |
| exfoliant/scrub | 1 products |
| baby bubble bath | 1 products |
| makeup primer | 1 products |
Allergies/immunotoxicity
| Concern | Reference |
|---|---|
| Limited evidence of [[system]] toxicity or allergies | European Chemicals Agency (ECHA) 2018. GHS Data from ECHA Website. Appears as: chemical_names: Matricaria recutita, ext.; -; blue chamomile oil; Chamomile (flower oil); Chamomile essential oil; Chamomile oil blue; Chamomile oil, Blue; Essential oil of Matricaria recutita (Asteraceae) obtained from flower tops by steam distillation of Egypt orig; cas_numbers: 8002-66-2, 84082-60-0 |
| Safe for use when formulated to be non-sensitizing | Cosmetic Ingredient Review (CIR) 2015. CIR Assessments. Appears as: listid: CIR-3131; Chemical_Name: Chamomilla recutita (matricaria) flower water; ; ; Classification: QQQ02, QQQ54; |
Developmental/reproductive toxicity
| Concern | Reference |
|---|---|
| Weak evidence of possible pregnancy/birth effects associated with chamomile consumption. | Laura Cuzzolin, Francesco Francini-Pesenti, Giovanna Verlato, Marco Joppi, Paola Baldelli & Giuseppina Benoni 2010. Use of herbal products among 392 Italian pregnant women: focus on pregnancy outcome. Pharmacoepidemiology and drug safety 19(11), 1151-8. |
Neurotoxicity
| Concern | Reference |
|---|---|
| Derivatives of C. recutita may impact behavioral/neurological endpoints in humans. | Sepide Miraj & Samira Alesaeidi 2016. A systematic review study of therapeutic effects of Matricaria recuitta chamomile (chamomile). Electronic physician 8(9), 3024-3031. |
Use restrictions
| Concern | Reference |
|---|---|
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | Final report 12/2013 available from CIR |
| Safe for use in cosmetics with some qualifications | Cosmetic Ingredient Review (CIR) 2015. CIR Assessments. Appears as: listid: CIR-3131; Chemical_Name: Chamomilla recutita (matricaria) flower water; ; ; Classification: QQQ02, QQQ54; |
Data gaps
| Concern | Reference |
|---|---|
| 59 studies in PubMed science library may include information on the toxicity of this chemical | NLM PubMed |
Data Sources
- European Chemicals Agency (ECHA) 2018. GHS Data from ECHA Website. Appears as: chemical_names: Matricaria recutita, ext.; -; blue chamomile oil; Chamomile (flower oil); Chamomile essential oil; Chamomile oil blue; Chamomile oil, Blue; Essential oil of Matricaria recutita (Asteraceae) obtained from flower tops by steam distillation of Egypt orig; cas_numbers: 8002-66-2, 84082-60-0
- Cosmetic Ingredient Review (CIR) 2015. CIR Assessments. Appears as: listid: CIR-3131; Chemical_Name: Chamomilla recutita (matricaria) flower water; ; ; Classification: QQQ02, QQQ54;
- Laura Cuzzolin, Francesco Francini-Pesenti, Giovanna Verlato, Marco Joppi, Paola Baldelli & Giuseppina Benoni 2010. Use of herbal products among 392 Italian pregnant women: focus on pregnancy outcome. Pharmacoepidemiology and drug safety 19(11), 1151-8.
- Sepide Miraj & Samira Alesaeidi 2016. A systematic review study of therapeutic effects of Matricaria recuitta chamomile (chamomile). Electronic physician 8(9), 3024-3031.
- Final report 12/2013 available from CIR
- NLM (National Library of Medicine). 2012. PubMed online scientific bibliography data. http://www.pubmed.gov.
ABOUT THE SKIN DEEP® RATINGS
EWG provides information on personal care product ingredients from the published scientific literature, to supplement incomplete data available from companies and the government. The ratings below indicate the relative level of concern posed by exposure to the ingredients in this product - not the product itself - compared to other product formulations. The ratings reflect potential health hazards but do not account for the level of exposure or individual susceptibility, factors which determine actual health risks, if any. Learn more | Legal Disclaimer
ABOUT EWG VERIFIED™
Beyond providing Skin Deep® as an educational tool for consumers, EWG offers its EWG VERIFIED™ mark as a quick and easily identifiable way of conveying personal care products that meet EWG's strict health criteria. Before a company can use EWG VERIFIED™ on such products, the company must show that it fully discloses the products' ingredients on their labels or packaging, they do not contain EWG ingredients of concern, and are made with good manufacturing practices, among other criteria. Note that EWG receives licensing fees from all EWG VERIFIED™ member companies that help to support the important work we do. Learn more | Legal Disclaimer
